[go: up one dir, main page]

FR2944015B1 - Nouveaux peptides eclaircissants activateurs du proteasome et compositions les contenant - Google Patents

Nouveaux peptides eclaircissants activateurs du proteasome et compositions les contenant

Info

Publication number
FR2944015B1
FR2944015B1 FR0901611A FR0901611A FR2944015B1 FR 2944015 B1 FR2944015 B1 FR 2944015B1 FR 0901611 A FR0901611 A FR 0901611A FR 0901611 A FR0901611 A FR 0901611A FR 2944015 B1 FR2944015 B1 FR 2944015B1
Authority
FR
France
Prior art keywords
activatory
lightening
peptides
compositions containing
containing same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0901611A
Other languages
English (en)
Other versions
FR2944015A1 (fr
Inventor
Farra Claude Dal
Nouha Domloge
Jean Marie Botto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISP Investments LLC
Original Assignee
ISP Investments LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISP Investments LLC filed Critical ISP Investments LLC
Priority to FR0901611A priority Critical patent/FR2944015B1/fr
Priority to PCT/FR2010/000281 priority patent/WO2010112713A2/fr
Publication of FR2944015A1 publication Critical patent/FR2944015A1/fr
Application granted granted Critical
Publication of FR2944015B1 publication Critical patent/FR2944015B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
FR0901611A 2009-04-02 2009-04-02 Nouveaux peptides eclaircissants activateurs du proteasome et compositions les contenant Expired - Fee Related FR2944015B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0901611A FR2944015B1 (fr) 2009-04-02 2009-04-02 Nouveaux peptides eclaircissants activateurs du proteasome et compositions les contenant
PCT/FR2010/000281 WO2010112713A2 (fr) 2009-04-02 2010-04-01 Nouveaux peptides eclaircissants activateurs du proteasome et compositions les contenant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0901611A FR2944015B1 (fr) 2009-04-02 2009-04-02 Nouveaux peptides eclaircissants activateurs du proteasome et compositions les contenant

Publications (2)

Publication Number Publication Date
FR2944015A1 FR2944015A1 (fr) 2010-10-08
FR2944015B1 true FR2944015B1 (fr) 2012-03-09

Family

ID=41509057

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0901611A Expired - Fee Related FR2944015B1 (fr) 2009-04-02 2009-04-02 Nouveaux peptides eclaircissants activateurs du proteasome et compositions les contenant

Country Status (2)

Country Link
FR (1) FR2944015B1 (fr)
WO (1) WO2010112713A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024000088A1 (fr) * 2022-06-27 2024-01-04 欧诗漫生物股份有限公司 Polypeptide éclaircissant dérivé de perles et son utilisation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3100005B2 (ja) * 1992-07-28 2000-10-16 雪印乳業株式会社 ヒト免疫不全ウィルス感染・増殖抑制剤
FR2864085B1 (fr) * 2003-12-18 2010-09-17 Centre Nat Rech Scient Nouveaux modulateurs du proteasome
EP1830873A4 (fr) * 2004-12-10 2008-04-02 Protemix Corp Ltd Glyponectine (adiponectine glycosylee) pour le traitement de maladies et d'etats pathologiques

Also Published As

Publication number Publication date
WO2010112713A3 (fr) 2010-11-25
FR2944015A1 (fr) 2010-10-08
WO2010112713A2 (fr) 2010-10-07

Similar Documents

Publication Publication Date Title
FR2944797B1 (fr) Hydrolysats peptidiques activateurs du proteasome et compositions les contenant
IL204183A (en) Preparations and Methods for Using Froisslet Peptides and Their Analogs
DK1996621T3 (da) Antistoffer mod beta-amyloid-peptid
EP2504353A4 (fr) Compositions de lipopeptides et procédés apparentés
EP2360208A4 (fr) Composition contenant un carbodiimide cyclique
SMT201600249B (it) Composizioni farmaceutiche acquose contenenti complessi borato- poliolo
EP2753367A4 (fr) Signature olfactive et mélange odorant la contenant
PL3178490T3 (pl) Kompozycje białka f rsv i sposoby ich wytwarzania
IL209136A0 (en) Compositions of peptides and processes of preparation thereof
EP2167043A4 (fr) Compositions nutraceutiques de co-cristal
EP2593797A4 (fr) Nouveaux procédés d'évolution protéique
EP2213296A4 (fr) Composition médicinale contenant une protéine chimère extrêmement fonctionnalisée
EP2274413A4 (fr) Contenant de cellules
EP2506709A4 (fr) Compositions d'amantadine et procédés d'utilisation associés
EP2610280A4 (fr) Polymère contenant un cycle triazine et composition formant membrane le contenant
EP2279739A4 (fr) Préparation de patch contenant du donézépil et conditionnement
IL219470A0 (en) Compositions containing fractalknie-binding proteins and uses thereof
EP2258426A4 (fr) Contenant de médicament
FR2940969B1 (fr) Nouveaux peptides anti-age et composition cosmetique et/ou pharmaceutique les contenant
BRPI1011434A2 (pt) metodos de analisar misturas de peptideo
EP2111837A4 (fr) Bande de soudage pour capsules dures contenant du peg encapsulé
FR2944798B1 (fr) Hydrolysats peptidiques eclaircissants activateurs du proteasome et compositions les contenant
EP2635570A4 (fr) Nouveaux inhibiteurs spécifiques de la protéase ns3 du vhc
EP2634548A4 (fr) Contenant
FR2944018B1 (fr) Nouveaux peptides anti-age activateurs du proteasome et compositions les contenant

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

ST Notification of lapse

Effective date: 20200108